This Prize of 75,000 €, is a triennial and international Prize, intended to reward a researcher or doctor whose work will have contributed to the cure of a disease still incurable to date, or whose research leads to the hope of a close cure.
👨🔬 The 2021 Prize was awarded to Prof. Guillaume CANAUD from Hôpital Necker-Enfants Malades, University of Paris for his contributions to the therapy of a spectrum of overgrowth syndromes characterized by the presence of genetic alterations in a gene called PIK3CA and grouped together under the acronym PROS (PIK3CA-related overgrowth syndrome).
👨🔬 The 2021 Prize was awarded to Prof. Guillaume CANAUD from Hôpital Necker-Enfants Malades, University of Paris for his contributions to the therapy of a spectrum of overgrowth syndromes characterized by the presence of genetic alterations in a gene called PIK3CA and grouped together under the acronym PROS (PIK3CA-related overgrowth syndrome).
